CLINSQUARE: CLINICAL RESEARCH COURSES
Saturday, May 10, 2025
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home2020May

Monthly Archives: May, 2020

Libtayo® longer-term results presented at ASCO 2020 in advanced cutaneous squamous cell carcinoma

admin - 0
Libtayo® (cemiplimab-rwlc) longer-term results in advanced cutaneous squamous cell carcinoma presented at ASCO 2020 show durable responses that deepen over time. May 29, 2020: "New,...

CHMP recommends EU approval of Roche’s Rozlytrek

admin - 0
CHMP recommends EU approval of Roche’s Rozlytrek for people with NTRK fusion-positive solid tumours and for people with ROS1-positive, advanced non-small cell lung cancer May...

Pfizer’s update on phase 3 Pallas Trial of Ibrance® in HR+, HER2- early Breast Cancer

admin - 0
May 29, 2020: "Pfizer announced by the Austrian Breast & Colorectal Cancer Study Group and the Alliance Foundation Trials, LLC, Pfizer Inc. reports that...

XTANDI® extends overall survival in men with non-metastatic castration-resistant prostate cancer

admin - 0
May 29, 2020: "Pfizer Inc. and Astellas Pharma Inc. have announced final results from the overall survival (OS) analysis of the Phase 3 PROSPER trial, which...

Novartis announces long-term, relapse-free survival benefit for high-risk, stage III melanoma patients

admin - 0
May 29, 2020: "Novartis announced updated results from the landmark COMBI-AD clinical trial, demonstrating that treatment with Tafinlar® (dabrafenib) and Mekinist® (trametinib) following the surgical removal...

Novartis Piqray® receives positive CHMP opinion to treat HR+/HER2- advanced breast cancer with a PIK3CA mutation

admin - 0
May 29, 2020: "Novartis announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion...

Coronavirus (COVID-19) Update: Daily Roundup May 29, 2020

admin - 0
May 29, 2020: "The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: FDA is...

FDA Approves New Option to Treat Heavy Menstrual Bleeding Associated with Fibroids

admin - 0
May 29, 2020: "The U.S. FDA granted approval to Oriahnn (an estrogen and progestin combination product consisting of elagolix, estradiol and norethindrone acetate)...

FDA OK’s TAUVID™ for Use in Patients Evaluated for Alzheimer’s Disease

admin - 0
May 28, 2020: "TAUVID™, a radioactive diagnostic agent, has been approved by the FDA for positron emission tomography (PET) imaging of the brain to...

GSK to produce1 billion doses of pandemic vaccine adjuvant

admin - 0
May 28, 2020: "GSK confirmed its intention to manufacture 1 billion doses of its pandemic vaccine adjuvant system, in 2021, to support the development...

Tagrisso demonstrated unprecedented disease-free survival in lung cancer

admin - 0
May 28, 2020: "Detailed results from the Phase III ADAURA trial showed AstraZeneca’s Tagrisso (osimertinib) demonstrated a statistically significant and clinically meaningful improvement in disease-free survival...

Roche’s Alecensa increases the overall survival rate for people with ALK-positive non-small cell lung cancer

admin - 0
May 29, 2020: Roche presented updated data from the pivotal phase III ALEX study, showing an increased five-year survival rate with Alecensa® (alectinib), compared...
123...13Page 1 of 13
- Advertisment -

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

LifeProNow provides guidance and high quality contents to help job seekers to get their dream Job. All the contents are written by experienced folks and peer reviewed by experts.

Contact us: [email protected]

FOLLOW US

© LifeProNow | All Rights Reserved